SFRP5 and type 2 diabetes mellitus: In Chinese subjects, both reductions and increases in circulating Sfrp5 levels between obese and T2D patients versus control participants were reported [11]–[13], while no differences were observed between lean and obese Caucasian subjects [14], [15].